data of study “Clinical characteristics and outcome of treatment-refractory myasthenia gravis in a Chinese cohort”

Our study delineated the frequency and clinical characteristics of treatment-resistant MG in mainland China, despite patients receiving adequate doses of corticosteroids and at least two concurrent immunosuppressive drugs for a minimum of one year. A key strength of this study lies in addressing the ambiguity surrounding the assessment of clinical symptoms in the ICG criteria by incorporating findings from various original researches[23-26]. Our approach focused on utilizing operational assessment of clinical symptoms, in contrast to previous definitions of refractory MG